To make early disease detection accessible, affordable, and environmentally sustainable through AI-powered retinal imaging.
Cosmora is developing cutting-edge AI models that analyze retinal photographs to detect systemic diseases. Our mission is to redefine how early diagnosis is achieved by turning a simple eye image into a powerful, non-invasive diagnostic tool.
Every blood vessel in the retina tells a story about systemic health. By using deep learning, Cosmora identifies microvascular patterns and subtle changes that correspond to early signs of disease, long before symptoms appear.
Cosmora is a medical technology startup founded by aspiring physicians passionate about using artificial intelligence to improve global health. Our team brings together expertise in ophthalmology, machine learning, and clinical research.
We are currently collecting retinal image data from partner institutions to train and validate our first clinical model. This model will serve as proof of concept for our broader platform, which aims to identify a range of systemic diseases from fundus images.
Chief Executive Officer
Chief Technology Officer
Chief Operations Officer
Chief Information Officer
Image Capture: First, a retinal fundus photo is captured.
AI Analysis: Our neural network analyzes the fundus photo to screen for patterns associated with disease.
Clinical Insight: The system outputs disease probability and highlights areas of interest, indicating if further investigation is warranted.